INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF)
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.
Open INTERNATIONAL FLAVORS & FRAGRANCES INC in the interactive graph- Ticker
- IFF
- SEC CIK
- 0000051253
- Sector
- Materials
- Industry
- Chemicals
- Periods
- FY2025 Q1, FY2026, FY2026 Q1, FY2026 Q3, FY2027
- Headquarters
- New York, NY
- Employees
- 21,500
Key figures
- Revenue 2.74B USD
- NetIncome 211.00M USD
- DilutedEPS 0.66 USD/share
Reported figures
- BasicSharesOutstanding 256,000,000.00 shares
- CapitalExpenditure 165.00M USD
- CapitalExpenditure 179.00M USD
- CashAndEquivalents 562.00M USD
- CostOfRevenue 1.72B USD
- CostOfRevenue 1.81B USD
- DilutedEPS -3.98 USD/share
- DilutedEPS 0.66 USD/share
- EBITDA 111.00M USD
- EBITDA 114.00M USD
- EBITDA 131.00M USD
- EBITDA 138.00M USD
- EBITDA 144.00M USD
- EBITDA 148.00M USD
- EBITDA 153.00M USD
- EBITDA 568.00M USD
- EBITDA 578.00M USD
- EBITDAMargin 13.6 percent
- EBITDAMargin 13.9 percent
- EBITDAMargin 20.3 percent
- EBITDAMargin 20.7 percent
- EBITDAMargin 20.9 percent
- EBITDAMargin 22.7 percent
- EBITDAMargin 23.3 percent
- EBITDAMargin 23.5 percent
- EBITDAMargin 25.6 percent
- EBITDAMargin 25.7 percent
- FreeCashFlow 92.00M USD
- GrossProfit 1.02B USD
- GrossProfit 1.03B USD
- InterestExpense 44.00M USD
- InterestExpense 71.00M USD
- NetIncome -1.02B USD
- NetIncome 169.00M USD
- NetIncome 198.00M USD
- NetIncome 211.00M USD
- OperatingCashFlow 127.00M USD
- OperatingCashFlow 257.00M USD
- OperatingIncome -903.00M USD
- OperatingIncome 273.00M USD
- and 21 more in the interactive graph
Guidance
- EBITDA guidance 2.05B–2.15B USD
- Revenue guidance 10.50B–10.80B USD
Drivers
- Broad-based growth across all businesses drove comparable currency neutral sales increase
- Broad-based growth in all regions drove Taste segment sales increase
- Growth in Consumer Fragrances and Fine Fragrances partially offset by decline in Fragrance
- Growth in nearly all businesses, led by Animal Nutrition and Food Biosciences, drove Healt
- Productivity gains improved profitability in the first quarter
- Volume growth and productivity gains drove 12% increase in Food Ingredients adjusted opera
- Volume growth and productivity gains drove 8% improvement in comparable currency neutral a
- Volume growth and productivity gains more than offset by unfavorable price to input cost i
- Volume growth in all four segments contributed to first quarter results
- Volume growth in nearly all businesses led Food Ingredients sales increase
- Volume growth primarily drove 7% increase in Health & Biosciences adjusted operating EBITD
- Volume growth, favorable net pricing and productivity gains led to 18% increase in Taste a
Risks
- Current operating environment remains unsettled
- Demand trends, competitive dynamics and customer concentration in end markets
- Exposure to emerging markets, foreign currency fluctuations and international regulatory a
- Indebtedness, credit rating, liquidity, and access to capital
- Tariffs and trade actions, supply chain disruptions and macro events, including geopolitic
- Volatility in input costs such as raw materials, transportation and energy
Corporate events
- Cash dividends paid to shareholders of $102 million in Q1 2026
- Company is progressing disciplined sale process for Food Ingredients business
- Divestiture of Nitrocellulose business on May 9, 2025
- Divestiture of Pharma Solutions disposal group on May 1, 2025
- Divestiture of Rene Laurent business on December 1, 2025
- Divestiture of Soy Crush, Concentrates, and Lecithin business closed on March 2, 2026
- IFF Productivity Program with severance costs of $6 million in Q1 2026
- Purchases of treasury stock of $35 million in Q1 2026
Quotes
- “As we look ahead, we are maintaining a disciplined approach to how we are planni…”